Weaver syndrome is a rare genetic overgrowth disorder in which children grow unusually fast before and after birth, develop advanced bone maturation, and have a distinctive set of facial features. It is caused by mutations in the EZH2 gene, a discovery made in 2011 using whole-exome sequencing of affected families. Because the condition is so uncommon and shares features with other overgrowth syndromes, it often takes years to diagnose, and much of what clinicians know still comes from individual case reports rather than large studies.
What Causes Weaver Syndrome
The root of Weaver syndrome lies in mutations affecting a gene called EZH2, which stands for enhancer of zeste homolog 2. EZH2 is part of a protein group known as polycomb repressive complex 2 (PRC2), a molecular machine that helps silence certain genes during development by chemically tagging a specific spot on histone proteins. When EZH2 works normally, it keeps particular growth-related genes switched off at the right times. In Weaver syndrome, mutations reduce that silencing ability, leading to a partial loss of function rather than a complete shutdown of the protein.1PubMed Central. Mutations in EZH2 Cause Weaver Syndrome
The discovery came from trio-based exome sequencing of two families with Weaver syndrome, including one of the original families described when the condition was first reported in 1974. Researchers filtered rare genetic variants in the affected children against those found in their unaffected parents and identified de novo mutations in EZH2, meaning the mutations were new and not inherited from either parent.2PubMed Central. Germline mutations in the oncogene EZH2 cause Weaver syndrome and increased human height Most cases arise this way, so parents of a child with Weaver syndrome typically do not carry the mutation themselves.
More recently, mutations in two other genes, EED and SUZ12, have also been linked to Weaver syndrome or a closely related presentation sometimes called “Weaver-like” syndrome. Like EZH2, both EED and SUZ12 are core parts of PRC2. Laboratory testing has shown that missense mutations in EED and SUZ12 reduce the same histone-tagging activity that EZH2 mutations disrupt, reinforcing the idea that anything that weakens PRC2 function can produce the Weaver phenotype.3PubMed. Mutations in genes encoding polycomb repressive complex 2 subunits cause Weaver syndrome Mutations in SUZ12 specifically have been found in individuals whose features overlap heavily with classic Weaver syndrome.4PubMed. Novel SUZ12 mutations in Weaver-like syndrome
How the Mutations Affect Growth and Bones
The hallmark of Weaver syndrome is overgrowth. Affected children are typically large at birth and continue to grow at a pace well above average through childhood. Accelerated growth is accompanied by advanced bone age, meaning a child’s skeleton matures faster than expected for their chronological age.5PubMed. The difficulty of height prediction in Weaver syndrome This combination of tall stature and accelerated skeletal maturation is among the most consistent findings in the syndrome.6PubMed Central. A New Case with Weaver Syndrome: Delineating Natural Course and Growth Pattern, Further Clarifying Clinical Phenotype
An important question is what is happening inside the bones themselves. A mouse model carrying one of the Weaver-associated EZH2 mutations (the R684C variant) showed that the overgrowth is linked to increased bone formation, particularly in the thick outer layer of long bones known as cortical bone. In female mice carrying the mutation, osteoblast activity (the cells that build bone) was markedly higher than in their unaffected littermates, and the cross-sectional area of the femur was significantly increased. Intriguingly, these bone changes could be reversed by inhibiting enzymes called KDM6A and KDM6B, which oppose PRC2’s silencing activity.7PubMed Central. A mouse model of Weaver syndrome displays overgrowth and excess osteogenesis reversible with KDM6A/6B inhibition This reversal in mice is an early signal that therapeutic intervention might one day be possible, though the research is still preclinical.
Despite the rapid skeletal maturation, predicting final adult height in Weaver syndrome is difficult. The advanced bone age might suggest that growth plates would close early, limiting eventual height. But in practice, growth trajectories vary considerably from person to person, and standard clinical formulas for predicting adult height do not work well for these children.
Recognizable Facial and Physical Features
Beyond tall stature, Weaver syndrome has a set of facial characteristics that experienced clinicians can recognize. These typically include a broad forehead, widely spaced eyes, almond-shaped eye openings, and large ears that sit lower on the head than usual. One of the most distinctive features is the chin: it tends to look pointed with a horizontal skin crease running across it, sometimes described as “stuck-on” in appearance. In early childhood, the ears may appear fleshy, and the lower jaw can be slightly recessed.8Molecular Syndromology. Expanding the Phenotypic and Genotypic Spectrum of Weaver Syndrome: A Missense Variant of the EZH2 Gene9PubMed Central. Clinical and genetic characterization of Weaver syndrome: A case report of an EZH2 mutation and review of the literature
Other physical signs include camptodactyly, a condition where the fingers are permanently bent at one of the joints, and prominent fingertip pads with thin, deep-set nails.10BMJ Journals. The syndromes of Marshall and Weaver Macrocephaly, or a head circumference larger than the 97th percentile, is common. Some infants have a hoarse, low-pitched cry. Umbilical hernia has been reported in multiple cases. Increased muscle tone (hypertonia) in infancy can also be a feature, which is somewhat unusual among overgrowth syndromes, where low tone is more typical.
Intellectual Development and Brain Findings
Developmental delay in Weaver syndrome is variable. Some children meet milestones on time or only slightly behind, while others have more significant intellectual disability. The degree of delay does not seem to follow a predictable pattern based on which specific EZH2 mutation is present, which makes counseling families about long-term cognitive outcomes challenging.
Brain imaging in documented cases has occasionally revealed structural abnormalities. Among cases where brain MRI was performed and abnormalities were found, ventriculomegaly (enlarged fluid-filled spaces in the brain) was the most frequently reported finding, documented in six cases in a recent literature review. Two cases showed abnormalities in the brain’s surface folding pattern.11PubMed Central. Clinical and genetic characterization of Weaver syndrome: A case report of an EZH2 mutation and review of the literature These findings are not present in every child with the syndrome, and they do not always correlate neatly with the severity of developmental difficulties.
Cancer Risk in Weaver Syndrome
Overgrowth syndromes as a group carry an increased risk of tumors, and Weaver syndrome appears to be no exception, though the evidence base is small. The most commonly reported malignancy in Weaver syndrome is neuroblastoma, a cancer of immature nerve cells that usually affects very young children. At least four cases of neuroblastoma in children with Weaver syndrome have been documented, with onset typically in the first year of life.12PubMed. Weaver syndrome and neuroblastoma13Laboratory Medicine Online. First Korean Case of Weaver Syndrome Along with Neuroblastoma and Genetic Confirmation of EZH2 Variant
Other cancers reported in Weaver syndrome include acute lymphoblastic leukemia, acute myeloid leukemia, lymphoma, teratoma, and ovarian tumors, though each of these has been reported in only one or two cases. One literature review that tallied all published Weaver syndrome cases found that roughly 11% had developed tumors or blood cancers, but the authors emphasized that this figure is almost certainly inflated. Cases that involve a dramatic complication like cancer are more likely to be published than uncomplicated cases, which creates reporting bias.14PubMed. Acute lymphoblastic leukemia in Weaver syndrome
The biological plausibility is real, though. EZH2 is well established as an important gene in cancer biology. Somatic (non-inherited) mutations in EZH2 are found in several adult cancers, including lymphomas, prostate cancer, and breast cancer. The germline mutations seen in Weaver syndrome are functionally different from many of the somatic cancer-driver mutations, but the overlap is enough that researchers recommend ongoing cancer surveillance for children with the diagnosis. No formal screening protocol has been universally adopted, largely because the syndrome is too rare to study in a controlled way.15Laboratory Medicine Online. First Korean Case of Weaver Syndrome Along with Neuroblastoma and Genetic Confirmation of EZH2 Variant
Heart Defects and Other Systemic Features
Congenital heart defects have been reported in a handful of Weaver syndrome cases, but they are not considered a core feature of the condition. One reported patient had both a ventricular septal defect (a hole between the lower chambers of the heart) and a patent ductus arteriosus (a blood vessel that normally closes after birth but remained open).16American Journal of Medical Genetics. Weaver syndrome with neuroblastoma and cardiovascular anomalies Another patient, described as an 11-month-old Turkish infant, had an atrial septal defect along with a patent ductus arteriosus and was successfully operated on.17PubMed. A case with Weaver syndrome operated for congenital cardiac defect Because cardiovascular anomalies are not unusual in the general population either, it remains unclear whether they are a true part of the syndrome or coincidental findings in a very small sample. Still, a cardiac evaluation is reasonable at the time of diagnosis.
Distinguishing Weaver Syndrome from Sotos Syndrome
The condition most often confused with Weaver syndrome is Sotos syndrome, another overgrowth disorder that causes tall stature, advanced bone age, and developmental delay. The two overlap enough that before genetic testing was widely available, some researchers questioned whether they were the same condition. They are not. Sotos syndrome is caused by mutations in a different gene (NSD1), and although the two conditions share the broad strokes of overgrowth, experienced clinicians find the facial features convincingly different. In Sotos syndrome, the forehead is more prominent and the face tends to be longer, while in Weaver syndrome the chin crease and ear shape are more distinctive.18American Journal of Medical Genetics. The syndromes of Sotos and Weaver: Reports and review
Sotos syndrome also appears to carry a stronger association with cancer, whereas the cancer link in Weaver syndrome, as described above, is less clearly defined. Joint contractures and camptodactyly are more conspicuous in Weaver syndrome, while Sotos syndrome shows remarkably advanced dental maturation, a feature rarely commented on in Weaver cases.19American Journal of Medical Genetics. The syndromes of Sotos and Weaver: Reports and review Today, when genetic testing is accessible, the distinction is usually resolved by identifying which gene is mutated. But in cases where sequencing returns a variant of uncertain significance, the clinical differences remain valuable.
Using DNA Methylation Patterns for Diagnosis
One of the more interesting diagnostic advances for Weaver syndrome is the development of a DNA methylation “episignature.” Because EZH2 mutations alter how genes are silenced through histone modification, they leave a characteristic chemical fingerprint on DNA methylation across the genome. Researchers analyzing genome-wide methylation data from 187 individuals with overgrowth disorders and 969 control subjects showed that EZH2 mutations produce a highly specific and sensitive methylation pattern that distinguishes Weaver syndrome from other overgrowth conditions.20PubMed Central. DNA Methylation Signature for EZH2 Functionally Classifies Sequence Variants in Three PRC2 Complex Genes
This matters for a practical reason. When genetic sequencing finds a variant in EZH2 but it is unclear whether that variant is disease-causing or harmless, the methylation signature can help resolve the question. The test can also distinguish between loss-of-function mutations (the type that cause Weaver syndrome) and gain-of-function mutations in the same gene (the type associated with certain cancers), and can even detect cases of somatic mosaicism, where the mutation is present in only some of a person’s cells.21American Journal of Human Genetics. Genome-wide DNA Methylation Episignatures Highlight that Genetic Variants in EZH2, EED, and SUZ12 Form a Molecular and Clinical Continuum For families who have spent years pursuing a diagnosis, this kind of confirmatory testing can be the difference between a clear answer and indefinite uncertainty.
Early Research into Gene Editing Therapy
Because Weaver syndrome is caused by a single-gene mutation and follows a dominant inheritance pattern, it is a logical candidate for gene-editing approaches. A recent study tested four different CRISPR strategies in mouse cell lines carrying a humanized version of a common Weaver-associated EZH2 mutation (the R684C variant). The researchers found that one approach using a smaller bacterial enzyme called SaCas9 corrected about half of the disease-causing copies of the gene while leaving the healthy copy largely intact, altering it in only about 2% of cases. A more commonly used enzyme, SpCas9, achieved higher correction rates of roughly 70%, but also damaged the healthy allele at a much higher rate of 21 to 26%, which would be a serious problem in treating a dominant condition where you need that healthy copy to function.22PubMed. Minimally Humanized Ezh2 Exon-18 Mouse Cell Lines Validate Preclinical CRISPR/Cas9 Approach to Treat Weaver Syndrome
The SaCas9 enzyme has an additional practical advantage: it is small enough to be packaged into delivery vehicles that could potentially be used in living patients, whereas larger enzymes face more logistical challenges getting into cells. This is very early-stage work in cell lines, not animal trials, let alone anything approaching human treatment. But for a syndrome that currently has no targeted therapy, any demonstration that the underlying mutation can be corrected with reasonable precision is a meaningful step. Given how recently the genetic cause of Weaver syndrome was even identified, the pace of translational research is notable.
How Weaver Syndrome Fits into the Broader Landscape of Overgrowth Disorders
Weaver syndrome belongs to a family of conditions sometimes grouped under “overgrowth and intellectual disability” (OGID). These include Sotos syndrome, Beckwith-Wiedemann syndrome, and several rarer entities. What links many of them is that they involve genes controlling how DNA is packaged and read, the so-called epigenetic machinery. PRC2 dysfunction in Weaver syndrome is one example; NSD1 mutations in Sotos syndrome affect a different part of the same landscape of gene regulation. The emerging picture is that small disruptions to the molecular systems that control when and where genes are turned on or off can have dramatic effects on body size and brain development.
This shared biology has practical implications. The DNA methylation episignature approach described above is not limited to Weaver syndrome; similar signatures have been developed for other OGID conditions, potentially allowing clinicians to screen for multiple syndromes simultaneously using a single blood sample. For families navigating the diagnostic odyssey that rare genetic conditions often entail, a single test that can distinguish between overlapping syndromes represents real progress. The fact that mutations in three different PRC2 genes (EZH2, EED, SUZ12) all converge on a recognizable clinical picture and a shared methylation pattern suggests they form a molecular continuum rather than strictly separate diseases.23American Journal of Human Genetics. Genome-wide DNA Methylation Episignatures Highlight that Genetic Variants in EZH2, EED, and SUZ12 Form a Molecular and Clinical Continuum24PubMed. Novel SUZ12 mutations in Weaver-like syndrome